Tolerability Safety and Efficacy of Sigh Breaths During NIMV in Motor Neuron Disease
-
- STATUS
- Recruiting
-
- participants needed
- 44
-
- sponsor
- Ospedale San Raffaele
Summary
Non-invasive mechanical ventilation (NIMV) is the recommended standard of care as initial therapy for patients with motor neuron disease (MND) with deterioration of the respiratory function.
SIGH_01 study is aimed at investigating the tolerability, safety profile and efficacy of sigh breaths during non-invasive mechanical ventilation in patients with MND in comparison to the standard ventilation support protocol.
Details
Condition | Myelopathy, Respiratory Failure, Respiratory Failure, Amyotrophic Lateral Sclerosis, Motor Neuron Disease |
---|---|
Age | 100years or below |
Treatment | NIMV with sigh breaths, Standard NIMV |
Clinical Study Identifier | NCT04240925 |
Sponsor | Ospedale San Raffaele |
Last Modified on | 16 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.